BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Cakal B, Uygunoglu U, Saip S, Altintas A, Siva A, Badur S
J Immunoassay Immunochem. 2014 Feb 18. PMID: 24547871.Abstract